VismoHisto
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Supporting data for JAAD manuscript entitled: Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular and superficial) of high risk and/or locally advanced basal cell carcinoma, in an open label prospective case series clinical trial.
创建时间：
2019-12-05
